Treatment of murine lupus with cDNA encoding IFN-γR/Fc
J. Clin. Invest. Brian R. Lawson, et al. 106:207 doi:10.1172/JCI10167 [Go to this article.]

Figure 1
Serum IFN-γ levels for treatment and control groups. Levels were determined by solid-phase ELISA. (a) Treatments initiated at 1 month of age without local electroporation. (b) Treatments initiated at 1 month of age with electroporation. (c) Treatments initiated at 4 months of age with electroporation. Circles, no treatment; squares, blank plasmid (VR1255); triangles, active plasmid (VR1255-IFN-γR/Fc). The mean and SEM are shown. In a, P < 0.001, and in b and c, P < 10^–6 between active plasmid– and blank plasmid–treated groups (n = 3–8).